An ovine transgenic Huntington's disease model

Human Molecular Genetics

Volumn 19, Issue 10, 2010, Pages 1873-1882

  Jacobsen, Jessie C ^a   Bawden, C Simon ^b   Rudiger, Skye R ^b   McLaughlan, Clive J ^b   Reid, Suzanne J ^a,c   Waldvogel, Henry J ^a   MacDonald, Marcy E ^d   Gusella, James F ^d   Walker, Simon K ^b   Kelly, Jennifer M ^b   Webb, Graham C ^e   Faull, Richard L M ^a   Rees, Mark I ^a,f,g   Snell, Russell G ^a,c  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b SOUTH AUSTRALIAN RESEARCH AND DEVELOPMENT INSTITUTE   (Australia)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f SWANSEA UNIVERSITY   (United Kingdom)

^g CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HUNTINGTIN; PHOSPHOPROTEIN DARPP 32; POLYGLUTAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN CORTEX; CAUDATE NUCLEUS; CONTROLLED STUDY; EMBRYO; FEMALE; FOUNDER EFFECT; GENE EXPRESSION; GENETIC MODEL; HUNTINGTON CHOREA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PUTAMEN; TRANSGENE; TRANSGENIC SHEEP;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BASAL GANGLIA; CHROMOSOMES, MAMMALIAN; DISEASE MODELS, ANIMAL; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; FEMALE; FOUNDER EFFECT; HUMANS; HUNTINGTON DISEASE; MALE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEDIGREE; RECEPTOR, CANNABINOID, CB1; SHEEP; TRANSGENES;

ANIMALIA; OVIS; OVIS ARIES;

EID: 77952526316     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq063     Document Type: Article

References (35)

1. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell, 72, 971-983.
2. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B.A., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W. et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell, 87, 493-506.
3. Scheerlinck, J.-P.Y., Snibson, K.J., Bowles, V.M. and Sutton, P. (2008) Biomedical applications of sheep models: from asthma to vaccines. Trends Biotechnol., 26, 259-266.
4. Adalsteinsson, S. and Basrur, P.K. (1984) Inheritance of spina bifida in Icelandic lambs. J. Hered., 75, 378-382.
5. Jolly, R.D., Martinus, R.D., Shimada, A., Fearnley, I.M. and Palmer, D.N. (1990) Ovine ceroid-lipofuscinosis is a proteolipid proteinosis. Can. J. Comp. Med., 54, 15-21.
6. Bawden, C.S., Powell, B.C., Walker, S.K. and Rogers, G.E. (1998) Expression of a wool intermediate filament keratin transgene in sheep fibre alters structure. Transgenic Res., 7, 273-287.
7. Schnieke, A.E., Kind, A.J., Ritchie, W.A., Mycock, K., Scott, A.R., Ritchie, M., Wilmut, I., Colman, A. and Campbell, K.H.S. (1997) Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. Science, 278, 2130-2133.
8. Brinster, R.L., Allen, J.M., Behringer, R.R., Gelinas, R.E. and Palmiter, R.D. (1988) Introns increase transcriptional efficiency in transgenic mice. Proc. Natl. Acad. Sci. USA, 85, 836-840.
9. Huang, M.T.F. and Gorman, C.M. (1990) Intervening sequences increase efficiency of RNA 3′ processing and accumulation of cytoplasmic RNA. Nucleic Acids Res., 18, 937-947.
10. Bawden, C.S., Sivaprasad, A.V., Verma, P.J., Walker, S.K. and Rogers, G.E. (1995) Expression of bacterial cysteine biosynthesis genes in transgenic mice and sheep: toward a new in vivo amino acid biosynthesis pathway and improved wool growth. Transgenic Res., 4, 87-104.
11. Kelly, J.M., Kleemann, D.O. and Walker, S.K. (2005) Enhanced efficiency in the production of offspring from 4-to 8-week-old lambs. Theriogenology, 63, 1876-1890.
12. Ross, C.A. (2002) Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron, 35, 819-822.
13. Harper, P.S. (1996) Huntington's Disease, W.B.Saunders, London.
14. Weeks, R.A., Piccini, P., Harding, A.E. and Brooks, D.J. (1996) Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease. Ann. Neurol., 40, 49-54.
15. Palmiter, R.D. and Brinster, R.L. (1986) Germ - line transformation of mice. Annu. Rev. Genet., 20, 465-499.
16. Telenius, H., Kremer, B., Goldberg, Y.P., Theilmann, J., Andrew, S.E., Zeisler, J., Adam, S., Greenberg, C., Ives, E.J., Clarke, L.A. et al. (1994) Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat. Genet., 6, 409-414.
17. Yang, S.-H., Cheng, P.-H., Banta, H., Piotrowska-Nitsche, K., Yang, J.-J., Cheng, E.C.H., Snyder, B., Larkin, K., Liu, J., Orkin, J. et al. (2008) Towards a transgenic model of Huntington's disease in a non-human primate. Nature, 453, 921-924.
18. Biglan, K.M., Ross, C.A., Langbehn, D.R., Aylward, E.H., Stout, J.C., Queller, S., Carlozzi, N.E., Duff, K., Beglinger, L.J., Paulsen, J.S. et al. (2009) Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study. Mov. Disord., 24, 1763-1772.
19. Duff, K., Paulsen, J.S., Beglinger, L.J., Langbehn, D.R. and Stout, J.C. (2007) Psychiatric symptoms in Huntington's disease before diagnosis: the Predict-HD study. Biol. Psychiatry, 62, 1341-1346.
20. Henley, S.M.D., Wild, E.J., Hobbs, N.Z., Frost, C., MacManus, D.G., Barker, R.A., Fox, N.C. and Tabrizi, S.J. (2009) Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease. Mov. Disord., 24, 932-936.
21. Johnson, S.A., Stout, J.C., Solomon, A.C., Langbehn, D.R., Aylward, E.H., Cruce, C.B., Ross, C.A., Nance, M., Kayson, E., Julian-Baros, E. et al. (2007) Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease. Brain, 130, 1732-1744.
22. Kloppel, S., Chu, C., Tan, G.C., Draganski, B., Johnson, H., Paulsen, J.S., Kienzle, W., Tabrizi, S.J., Ashburner, J., Frackowiak, R.S.J. et al. (2009) Automatic detection of preclinical neurodegeneration: presymptomatic Huntington disease. Neurology, 72, 426-431.
23. Kloppel, S., Draganski, B., Siebner, H.R., Tabrizi, S.J., Weiller, C. and Frackowiak, R.S.J. (2009) Functional compensation of motor function in pre-symptomatic Huntington's disease. Brain, 132, 1624-1632.
24. Paulsen, J.S. (2009) Biomarkers to predict and track diseases. Lancet Neurol., 8, 776-777.
25. Paulsen, J.S., Hayden, M., Stout, J.C., Langbehn, D.R., Aylward, E., Ross, C.A., Guttman, M., Nance, M., Kieburtz, K., Oakes, D. et al. (2006) Preparing for preventive clinical trials: the Predict-HD study. Arch. Neurol., 63, 883-890.
26. Paulsen, J.S., Langbehn, D.R., Stout, J.C., Aylward, E., Ross, C.A., Nance, M., Guttman, M., Johnson, S., MacDonald, M., Beglinger, L.J. et al. (2008) Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J. Neurol. Neurosurg. Psychiatr., 79, 874-880.
27. Saft, C., Schüttke, A., Beste, C., Andrich, J., Heindel, W. and Pfleiderer, B. (2008) fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease. Neuropsychologia, 46, 1279-1289.
28. Schippling, S., Schneider, S.A., Bhatia, K.P., Münchau, A., Rothwell, J.C., Tabrizi, S.J. and Orth, M. (2009) Abnormal motor cortex excitability in preclinical and very early Huntington's disease. Biol. Psychiatry, 65, 959-965.
29. Solomon, A.C., Stout, J.C., Johnson, S.A., Langbehn, D.R., Aylward, E.H., Brandt, J., Ross, C.A., Beglinger, L., Hayden, M.R., Kieburtz, K. et al. (2007) Verbal episodic memory declines prior to diagnosis in Huntington's disease. Neuropsychologia, 45, 1767-1776.
30. Tabrizi, S.J., Langbehn, D.R., Leavitt, B.R., Roos, R.A.C., Durr, A., Craufurd, D., Kennard, C., Hicks, S.L., Fox, N.C., Scahill, R.I. et al. (2009) Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol., 8, 791-801.
31. Persichetti, F., Trettel, F., Huang, C.C., Fraefel, C., Timmers, H.T.M., Gusella, J.F. and MacDonald, M.E. (1999) Mutant huntingtin forms in vivo complexes with distinct context-dependent conformations of the polyglutamine segment. Neurobiol. Dis., 6, 364-375.
32. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
33. Fusco, F.R., Chen, Q., Lamoreaux, W., Figueredo-Cardenas, G., Jiao, Y., Coffman, J.A., Surmeier, D.J., Honig, M.G., Carlock, L.R. and Reiner, A. (1999) Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease. J. Neurosci., 19, 1189-1202.
34. White, J.K., Auerbach, W., Duyao, M.P., Vonsattel, J.-P., Gusella, J.F., Joyner, A.L. and MacDonald, M.E. (1997) Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat. Genet., 17, 404-410.
35. Jones, A.L. (1999) The localization and interactions of huntingtin. Philos. Trans. R. Soc. Lond. B Biol. Sci., 354, 1021-1027.